Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › PA › SEWICKLEY › VALLEY MEDICAL FACILITIES INC

VALLEY MEDICAL FACILITIES INC

NPI: 1588770416 · SEWICKLEY, PA 15143 · General Acute Care Hospital · NPI assigned 08/22/2006

$4.22M
Total Medicaid Paid
137,432
Total Claims
126,064
Beneficiaries
173
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialROSENBERGER, ROBERT (CFO)
NPI Enumeration Date08/22/2006

Related Entities

Other providers sharing the same authorized official: ROSENBERGER, ROBERT

ProviderCityStateTotal Paid
ADENA HEALTH SYSTEM CHILLICOTHE OH $98.12M
VALLEY MEDICAL FACILITIES, INC. SEWICKLEY PA $19.37M
VALLEY MEDICAL FACILITIES INC BEAVER PA $10.29M
VALLEY MEDICAL FACILITIES, INC. SEWICKLEY PA $3.71M
VALLEY MEDICAL FACILITIES, INC. MC KEES ROCKS PA $1.86M
VALLEY MEDICAL FACILITIES INC MC KEES ROCKS PA $80K
VALLEY MEDICAL FACILITIES, INC. WEXFORD PA $32K
VALLEY MEDICAL FACILITIES, INC. BELLEVUE PA $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 223 $11K
2019 306 $8K
2020 14,218 $346K
2021 80,292 $2.11M
2022 17,453 $645K
2023 17,236 $771K
2024 7,704 $331K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 13,420 12,004 $1.42M
99283 Emergency department visit for the evaluation and management, moderate severity 9,017 8,033 $661K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,202 2,924 $420K
G0378 Hospital observation service, per hour 754 347 $199K
74177 Computed tomography, abdomen and pelvis; with contrast material 785 763 $141K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1,308 1,241 $114K
80053 Comprehensive metabolic panel 9,626 9,113 $104K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,516 3,357 $95K
T1015 Clinic visit/encounter, all-inclusive 1,757 525 $68K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 573 570 $56K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,954 9,423 $55K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,510 1,479 $50K
71275 Computed tomographic angiography, chest, with contrast material 241 233 $48K
70450 Computed tomography, head or brain; without contrast material 712 693 $40K
99282 Emergency department visit for the evaluation and management, low to moderate severity 945 898 $37K
71046 Radiologic examination, chest; 2 views 2,184 2,112 $32K
74176 Computed tomography, abdomen and pelvis; without contrast material 377 365 $31K
96375 Therapeutic injection; each additional sequential IV push 1,600 1,494 $28K
80050 General health panel 526 519 $27K
84443 Thyroid stimulating hormone (TSH) 1,081 1,059 $26K
80061 Lipid panel 1,705 1,687 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,688 2,536 $23K
84703 2,077 1,955 $20K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,484 2,405 $20K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 433 418 $18K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 71 65 $18K
93971 271 264 $16K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 446 438 $14K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 281 273 $14K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 428 420 $12K
76705 Ultrasound, abdominal, real time with image documentation; limited 323 315 $12K
76830 Ultrasound, transvaginal 240 231 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 791 757 $11K
84484 1,393 1,256 $10K
81003 3,460 3,307 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 153 151 $10K
72125 Computed tomography, cervical spine; without contrast material 160 156 $10K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 829 773 $10K
77067 Screening mammography, bilateral, including computer-aided detection 104 104 $9K
83690 1,927 1,808 $9K
83735 1,466 1,373 $9K
71045 Radiologic examination, chest; single view 1,119 1,074 $8K
80048 Basic metabolic panel (calcium, ionized) 1,043 955 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination 445 438 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 322 319 $7K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 322 319 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 167 160 $7K
83036 Hemoglobin; glycosylated (A1C) 907 896 $7K
96361 Intravenous infusion, hydration; each additional hour 500 483 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 265 257 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,853 1,764 $6K
85027 986 931 $6K
95886 106 101 $6K
83880 219 215 $6K
73610 288 275 $6K
84439 592 580 $5K
X0621 35 14 $5K
85730 925 877 $5K
87086 Culture, bacterial; quantitative colony count, urine 644 619 $5K
76536 90 90 $5K
88342 115 110 $5K
83605 711 657 $5K
86803 231 227 $5K
84702 278 208 $5K
86318 225 224 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 26 25 $4K
72100 219 212 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material 64 64 $4K
73630 358 342 $4K
82607 321 316 $4K
87040 248 238 $4K
73030 247 231 $4K
76801 85 81 $4K
70551 Magnetic resonance imaging, brain; without contrast material 14 14 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 43 38 $4K
86780 225 224 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 15 14 $4K
85610 1,153 1,065 $4K
82803 179 169 $4K
90837 Psychotherapy, 53 minutes with patient 72 56 $3K
36415 Collection of venous blood by venipuncture 12,329 10,981 $3K
71250 54 54 $3K
76775 70 70 $3K
73560 209 195 $3K
85378 318 311 $3K
73130 259 242 $3K
86850 411 394 $3K
80076 310 298 $3K
86702 221 219 $3K
97161 86 83 $3K
10060 25 24 $2K
86701 221 219 $2K
77063 Screening digital breast tomosynthesis, bilateral 81 81 $2K
87340 146 146 $2K
84145 131 129 $2K
87390 221 219 $2K
82728 178 173 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 34 27 $2K
74018 165 159 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 84 79 $2K
70486 28 27 $2K
86901 471 445 $2K
86900 471 445 $2K
82043 202 200 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 127 119 $2K
73110 133 129 $1K
93970 25 24 $1K
73502 74 72 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 44 39 $1K
87186 201 194 $1K
86618 53 53 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 29 28 $1K
95909 13 12 $1K
84153 42 42 $1K
82550 153 145 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 670 557 $999.90
85651 331 319 $990.91
96376 241 225 $983.20
90715 108 107 $790.72
86762 37 37 $773.37
86140 225 213 $673.03
74019 42 38 $635.29
J2270 Injection, morphine sulfate, up to 10 mg 1,042 799 $621.25
83550 111 108 $557.88
86038 37 36 $556.11
J1885 Injection, ketorolac tromethamine, per 15 mg 3,321 3,054 $514.96
82570 61 55 $464.40
73080 38 36 $450.80
82746 38 37 $414.46
82962 369 287 $374.42
87077 54 51 $326.55
82077 201 192 $322.73
J0696 Injection, ceftriaxone sodium, per 250 mg 338 305 $248.48
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,142 1,021 $219.19
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,388 2,927 $208.90
72040 14 12 $199.95
73590 12 12 $186.45
82784 13 12 $149.08
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 12 12 $148.42
J1200 Injection, diphenhydramine hcl, up to 50 mg 652 595 $141.27
J2765 Injection, metoclopramide hcl, up to 10 mg 477 439 $139.48
J2704 Injection, propofol, 10 mg 588 470 $138.26
76937 13 12 $98.40
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 14 13 $87.57
84100 15 13 $85.83
87070 12 12 $67.62
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 27 24 $65.97
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 80 56 $63.00
J3490 Unclassified drugs 35 28 $55.05
J3010 Injection, fentanyl citrate, 0.1 mg 586 439 $52.60
87081 13 12 $50.60
83516 28 26 $49.60
A9575 Injection, gadoterate meglumine, 0.1 ml 86 84 $42.91
85018 15 15 $40.55
J0690 Injection, cefazolin sodium, 500 mg 188 124 $38.48
88304 28 28 $29.20
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 150 100 $24.16
J2060 Injection, lorazepam, 2 mg 123 103 $23.71
J2370 Injection, phenylephrine hcl, up to 1 ml 16 12 $14.96
J1170 Injection, hydromorphone, up to 4 mg 17 12 $13.70
J2250 Injection, midazolam hydrochloride, per 1 mg 448 370 $13.15
J2795 Injection, ropivacaine hydrochloride, 1 mg 31 25 $5.44
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 40 37 $4.70
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 12 12 $1.41
3050F 406 401 $0.00
3051F 12 12 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 73 65 $0.00
3044F 577 568 $0.00
3048F 650 645 $0.00
3049F 466 464 $0.00
3011F 1,522 1,504 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 51 47 $0.00
3061F 42 42 $0.00